SAM #75F40126SSN135706

FDA Seeks Preventive and Corrective Maintenance Service for Biacore T200 SPR Instrument

The FDA's Center for Biologics Evaluations and Research (CBER), through its Office of Acquisitions and Grants Services (OAGS), is seeking a comprehensive service agreement for a Biacore T200 Surface Plasmon Resonance (SPR) instrument. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Biologics Evaluations and Research (CBER) - Office of Acquisitions and Grants Services (OAGS) - OEM Highlight: - Biacore (manufacturer of the T200 SPR instrument) - Requested Service: - Preventive and unlimited corrective repair service agreement for Biacore T200 SPR instrument (S/N: 28975001-2528993) - Service must include: - Annual preventive maintenance with full-system diagnostics and component exchange - Unlimited on-site corrective maintenance and emergency repairs (labor, travel, OEM-certified parts) - Priority technical support (8-hour remote response, on-site repair within 3 business days) - Unlimited access to OEM online support, software and firmware updates, and training - All maintenance performed to OEM standards with certified parts - Detailed service reports after each visit - Period of Performance: - Base year plus two one-year option periods - Notable Requirements: - All parts and maintenance must be OEM-certified - Service must provide rapid response and comprehensive coverage - Includes both preventive and emergency support

Description

See attached Sources Sought Notice (SSN) for a Preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, Base plus two (2) option years

View original listing